One meta-study found mortality was 37% lower on average in patients with PAP-treated OSA vs untreated OSA.

With a $1.1 billion settlement reached, the DreamStation difficulties may finally be over for Philips Respironics.

Medtrade exhibitor ResMed recently launched its AirCurve 11 series devices.

ResMed Inc. results for quarter ended Dec. 31, 2023 showed a 12% revenue increase to $1.2 billion.

From an idea in 1888 to a trusted company, Drive DeVilbiss has continued to thrive for 135 years.

Medtrade exhibitor CAIRE Inc has opened the doors of its new Global Service Headquarters in Canton, Ga.